
Researchers map and control pulmonary fibrosis signalling pathway in preclinical trials.
By uncovering the mechanism by which fibrous tissue cells in the lung multiply, researchers at The Children’s Hospital Los Angeles (CHLA), Keck School of Medicine, Nanjing Drum Tower Hospital, Instituto Nacional de Enfermedades Respiratorias, and McMaster University have identified a promising new approach for the treatment of pulmonary fibrosis. Idiopathic pulmonary fibrosis or IPF, where the disease appears spontaneously and without a known cause, is a severe, … Continue reading Researchers map and control pulmonary fibrosis signalling pathway in preclinical trials.